CLINICAL TRIALS PROFILE FOR MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
All Clinical Trials for mometasone furoate; olopatadine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02870205 ↗ | Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) | Completed | Glenmark Specialty S.A. | Phase 3 | 2016-08-01 | Study to evaluate the efficacy, safety and tolerability of GSP 301 NS compared with placebo NS and individual monotherapy formulations for the treatment of Seasonal Allergic Rhinitis (subjects 12 years of age and older) |
| NCT03444506 ↗ | Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR) | Completed | Glenmark Pharmaceuticals Ltd. India | Phase 2 | 2014-01-27 | A single-center, double-blind, placebo-controlled study of FDC olopatadine hydrochloride and mometasone furoate nasal spray (Molo; also referred as GSP 301) was conducted in subjects with seasonal allergic rhinitis. In this study, the efficacy and safety of two regimens (BID and QD) of the FDC (i.e. Molo 1 and Molo 2) were evaluated compared to placebo nasal spray, DYMISTA® and PATANASE®. |
| NCT06126952 ↗ | Azelastine Allergen Chamber - Onset of Action Study | Completed | MEDA Pharma GmbH & Co. KG | Phase 2 | 2023-10-30 | This study is to assess the Onset of Action and Efficacy of azelastine hydrochloride 0.15% in treating the nasal symptoms of seasonal allergic rhinitis (SAR) induced by an allergen challenge in an Environmental Exposure Unit (EEU) followed by a single dose and a 3-day treatment at home. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for mometasone furoate; olopatadine hydrochloride
Condition Name
Clinical Trial Locations for mometasone furoate; olopatadine hydrochloride
Trials by Country
Clinical Trial Progress for mometasone furoate; olopatadine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for mometasone furoate; olopatadine hydrochloride
Sponsor Name
